Bankrupt Mithra cashes in on remaining assets for $188.2m
Gedeon Richter gains rights to Mithra’s estetrol range in addition to subsidiaries Neuralis and Estetra.
Source: yahoo.com
Mayne Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mayne Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mayne Pharma Today - Breaking & Trending Today
Global Super Generics Market Report 2024: A $200 Billion
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the stock. TherapeuticsMD Trading Up 1.4 % TXMD stock opened at $2.14 on Friday. TherapeuticsMD has a fifty-two week low of $1.84 and a fifty-two week high […]
Source: theenterpriseleader.com
Why Appen, Mayne Pharma, Playside, and PYC shares are storming higher
Appen Ltd (ASX: APX) and Playside Studios Ltd (ASX: PLY) are two of four ASX shares rising on Friday. Here's why...
Source: fool.com.au
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com
Stock analysts at StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the stock. TherapeuticsMD Stock Down 3.6 % Shares of TherapeuticsMD stock opened at $2.14 on Friday. TherapeuticsMD has a 52 week low of $1.84 and a 52 […]
Source: wkrb13.com